Significant improvement in balance after four-week treatment with AM-125 20 mg nasal spray vs. placebo
Study provides proof-of-concept for enhancement and acceleration of vestibular recovery
Treatment
Highlights Company's progress to becoming a pure-play RNA business and tech strategy and penetrate the multi-billion TAM
HAMILTON, BERMUDA / ACCESSWIRE / May 18, 2022 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a
Altamira Therapeutics Ltd (NASDAQ: CYTO) shares are trading higher Monday after the company announced a peer-reviewed publication on positive in vitro data with its Bentrio drug-free nasal spray against the SARS-CoV-2 delta variant.
Altamira Therapeutics (NASDAQ:CYTO) will host a conference call at 08:00 AM ET on April 12, 2022, to discuss FY 2021 earnings results.
How to Attend Altamira Therapeutics (CYTO) Conference Call
Follow this link to access the live webcast.
Gainers
Marygold Companies (NYSE: MGLD) shares surged 89.4% to close at $4.11 on Friday after dropping 21% on Thursday.
TeraWulf Inc. (NASDAQ: WULF) gained 49.3% to close at $9.51.